{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:47:22Z","timestamp":1782362842453,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013395","name":"Sistema Nacional de Investigadores","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.pnpbp.2021.110473","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T21:36:02Z","timestamp":1636148162000},"page":"110473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients"],"prefix":"10.1016","volume":"113","author":[{"given":"Francisco","family":"Reyes-Madrigal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Guma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Le\u00f3n-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"G\u00f3mez-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Mora-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Kegeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Mallar","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"de la Fuente-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.pnpbp.2021.110473_bb0005","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2021.110473_bb0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuroimage.2016.10.027","article-title":"Manual segmentation of the fornix, fimbria, and alveus on high-resolution 3T MRI: application via fully-automated mapping of the human memory circuit white and grey matter in healthy and pathological aging","volume":"170","author":"Amaral","year":"2018","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110473_bb0015","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.neuroimage.2010.09.025","article-title":"A reproducible evaluation of ANTs similarity metric performance in brain image registration","volume":"54","author":"Avants","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.pnpbp.2021.110473_bb0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fninf.2014.00044","article-title":"The insight ToolKit image registration framework","volume":"8","author":"Avants","year":"2014","journal-title":"Front Neuroinform"},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110473_bb0025","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/schbul\/sbz076","article-title":"Anterior hippocampal-cortical functional connectivity distinguishes antipsychotic naive first-episode psychosis patients from controls and may predict response to second-generation antipsychotic treatment","volume":"46","author":"Blessing","year":"2020","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110473_bb0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41398-020-0812-z","article-title":"Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis","volume":"10","author":"Briend","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2021.110473_bb0035","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1176\/ajp.151.10.1430","article-title":"Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs","volume":"151","author":"Chakos","year":"1994","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110473_bb0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuroimage.2005.09.041","article-title":"The creation of a brain atlas for image guided neurosurgery using serial histological data","volume":"30","author":"Chakravarty","year":"2006","journal-title":"Neuroimage"},{"issue":"10","key":"10.1016\/j.pnpbp.2021.110473_bb0045","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/hbm.22092","article-title":"Performing label-fusion-based segmentation using multiple automatically generated templates","volume":"34","author":"Chakravarty","year":"2013","journal-title":"Hum. Brain Mapp."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110473_bb0050","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1006\/nimg.2001.0862","article-title":"A unified statistical approach to deformation-based morphometry","volume":"14","author":"Chung","year":"2001","journal-title":"Neuroimage"},{"issue":"9","key":"10.1016\/j.pnpbp.2021.110473_bb0055","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/npp.2011.65","article-title":"Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis","volume":"36","author":"de la Fuente-Sandoval","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.pnpbp.2021.110473_bb0060","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamapsychiatry.2013.289","article-title":"Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study","volume":"70","author":"de la Fuente-Sandoval","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2021.110473_bb0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biopsych.2017.09.028","article-title":"Prefrontal and striatal gamma-aminobutyric acid levels and the effect of antipsychotic treatment in first-episode psychosis patients","volume":"83","author":"de la Fuente-Sandoval","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2021.110473_bb0070","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","article-title":"Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function","volume":"75","author":"Demjaha","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2021.110473_bb0075","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/s41380-018-0082-9","article-title":"Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre (1)H-MRS study (OPTiMiSE)","volume":"23","author":"Egerton","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110473_bb0080","article-title":"Dopamine and glutamate in antipsychotic-responsive compared with antipsychotic-nonresponsive psychosis: A multicenter positron emission tomography and magnetic resonance spectroscopy study (STRATA)","author":"Egerton","year":"2020","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110473_bb0085","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.neuroimage.2011.09.012","article-title":"BEaST: brain extraction based on nonlocal segmentation technique","volume":"59","author":"Eskildsen","year":"2012","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110473_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12888-016-1177-y","article-title":"Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? A systematic review","volume":"17","author":"Gillespie","year":"2017","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110473_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pscychresns.2006.10.002","article-title":"Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug","volume":"154","author":"Glenthoj","year":"2007","journal-title":"Psychiatry Res."},{"issue":"12","key":"10.1016\/j.pnpbp.2021.110473_bb0100","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1176\/ajp.155.12.1711","article-title":"Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia","volume":"155","author":"Gur","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2021.110473_bb0105","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.biopsych.2018.09.009","article-title":"Glutamatergic Neurometabolite levels in patients with ultra-treatment-resistant schizophrenia: A cross-sectional 3T proton magnetic resonance spectroscopy study","volume":"85","author":"Iwata","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2021.110473_bb0110","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1176\/ps.46.8.801","article-title":"Effects of stringent criteria on eligibility for clozapine among public mental health clients","volume":"46","author":"Juarez-Reyes","year":"1995","journal-title":"Psychiatr. Serv."},{"issue":"8934","key":"10.1016\/j.pnpbp.2021.110473_bb0115","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(94)90599-1","article-title":"Changes in caudate volume with neuroleptic treatment","volume":"344","author":"Keshavan","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2021.110473_bb0120","doi-asserted-by":"crossref","first-page":"613764","DOI":"10.3389\/fpsyt.2021.613764","article-title":"Neuroimaging as a window into the pathophysiological mechanisms of schizophrenia","volume":"12","author":"Kraguljac","year":"2021","journal-title":"Front Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2021.110473_bb0125","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.biopsych.2015.08.017","article-title":"Toward illness phase-specific pharmacotherapy for schizophrenia","volume":"78","author":"Krystal","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"13","key":"10.1016\/j.pnpbp.2021.110473_bb0130","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1038\/npp.2009.94","article-title":"Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia","volume":"34","author":"Lahti","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.pnpbp.2021.110473_bb0135","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/070674371506001107","article-title":"Subtyping schizophrenia by treatment response: antipsychotic development and the central role of positive symptoms","volume":"60","author":"Lee","year":"2015","journal-title":"Can. J. Psychiatr."},{"issue":"2 Suppl","key":"10.1016\/j.pnpbp.2021.110473_bb0140","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2021.110473_bb0145","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/mp.2017.249","article-title":"Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention","volume":"23","author":"Lieberman","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110473_bb0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1004640408501","article-title":"Treatment refractory schizophrenia","volume":"71","author":"Lindenmayer","year":"2000","journal-title":"Psychiatr Q"},{"issue":"6","key":"10.1016\/j.pnpbp.2021.110473_bb0155","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/jamapsychiatry.2021.0380","article-title":"Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: A mega-analysis of individual participant-level data","volume":"78","author":"Merritt","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2021.110473_bb0160","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00406-010-0182-2","article-title":"Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics","volume":"261","author":"Molina","year":"2011","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110473_bb0165","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/schbul\/sbv151","article-title":"Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive","volume":"42","author":"Mouchlianitis","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.pnpbp.2021.110473_bb0170","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.euroneuro.2014.07.015","article-title":"Glutamate-mediated excitotoxicity in schizophrenia: a review","volume":"24","author":"Plitman","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.pnpbp.2021.110473_bb0175","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1038\/npp.2016.84","article-title":"Glutamatergic metabolites, volume and cortical thickness in antipsychotic-naive patients with first-episode psychosis: implications for excitotoxicity","volume":"41","author":"Plitman","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110473_bb0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/jamapsychiatry.2014.1734","article-title":"Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia","volume":"72","author":"Sarpal","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110473_bb0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpsychires.2020.02.032","article-title":"Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: implications for glutamate-mediated excitotoxicity","volume":"124","author":"Shah","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2021.110473_bb0190","doi-asserted-by":"crossref","first-page":"180107","DOI":"10.1038\/sdata.2018.107","article-title":"Warping an atlas derived from serial histology to 5 high-resolution MRIs","volume":"5","author":"Tullo","year":"2018","journal-title":"Sci Data"},{"key":"10.1016\/j.pnpbp.2021.110473_bb0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.schres.2017.11.038","article-title":"Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study","volume":"214","author":"Winterburn","year":"2019","journal-title":"Schizophr. Res."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621002323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621002323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:00:55Z","timestamp":1759521655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584621002323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":39,"alternative-id":["S0278584621002323"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110473","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110473"}}